secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2022-12-13T23:59:59+00:00
Accession:  0001213900-22-079522
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics appoints Dr. Jeff Pavell to board; CSO Stefanie Johns departs; shares authorized to 50M
--------------------------------------------------------------------------------

- Board expanded to five members; Dr. Jeff Pavell appointed Dec 7, 2022, and joins compensation committee.
- CSO Stefanie Johns employment terminated Dec 9, 2022; receives 6 months base salary and benefit continuation.
- Dr. Johns appointed to Scientific Advisory Board effective Dec 12, 2022.
- Shareholders approved increase in authorized common shares from 3M to 50M at Dec 12 special meeting.
- Vote: 11,881,817 for, 8,665,496 against, 3,690 abstain; amendment filed Dec 13.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022079522/0001213900-22-079522-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022079522/ea170029-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-079522

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer